These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 39031014)

  • 1. Second primary malignancies in women with breast cancer.
    Chen C; Tseng J; Amersi F; Silberman AW
    J Surg Oncol; 2024 Sep; 130(3):355-359. PubMed ID: 39031014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of second primary malignancy after breast cancer and related risk factors-Is breast-conserving surgery safe? A nested case-control study.
    Li Z; Wang K; Shi Y; Zhang X; Wen J
    Int J Cancer; 2020 Jan; 146(2):352-362. PubMed ID: 30861567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation-Associated Secondary Malignancies in BRCA Mutation Carriers Treated for Breast Cancer.
    Schlosser S; Rabinovitch R; Shatz Z; Galper S; Shahadi-Dromi I; Finkel S; Jacobson G; Rasco A; Friedman E; Laitman Y; Evron E; Bernstein R; Weiss I; Sklair-Levy M; Ben-David MA
    Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):353-359. PubMed ID: 32084523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathology of BRCA1- and BRCA2-associated Breast Cancers: Known and Less Known Connections.
    Fountzilas E; Konstantopoulou I; Vagena A; Apostolou P; Papadimitriou C; Christodoulou C; Tryfonopoulos D; Manousou K; Delimitsou A; Papamentzelopoulou M; Fountzilas G; Yannoukakos D; Fostira F
    Clin Breast Cancer; 2020 Apr; 20(2):152-159. PubMed ID: 31980407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Single-Center Retrospective Study of Patients with Double Primary Cancers: Breast Cancer and EGFR-Mutant Non-Small Cell Lung Cancer.
    Moran T; Quiroga V; Cirauqui B; Vila L; Gil-Moreno M; Carcereny E; Margeli M; Muñoz-Marmol A; Mate JL; Velarde JM; Molina MA; Rosell R
    Oncol Res Treat; 2019; 42(3):107-114. PubMed ID: 30799393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic features of breast cancers diagnosed in women treated with prior radiation therapy for Hodgkin lymphoma: Results from a population-based cohort.
    Wong SM; Ajjamada L; Weiss AC; Prakash I; Skamene S; Boileau JF; Pollak MN; Basik M
    Cancer; 2022 Apr; 128(7):1365-1372. PubMed ID: 34919263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second cancers after conservative surgery and radiation for stages I-II breast cancer: identifying a subset of women at increased risk.
    Fowble B; Hanlon A; Freedman G; Nicolaou N; Anderson P
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):679-90. PubMed ID: 11597809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The co-occurrence of breast cancer and soft tissue sarcoma in a single cohort series.
    Geva R; Jiveliouk I; Inbar M; Meller I; Friedman E; Merimsky O
    Am J Clin Oncol; 2009 Feb; 32(1):34-7. PubMed ID: 19194122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducing or Preventing Subsequent Malignancies for Breast Cancer Survivors? Double-edged Sword of Estrogen Receptor and Progesterone Receptor.
    Hu ZY; Xiao H; Xiao M; Tang Y; Sun J; Xie ZM; Ouyang Q
    Clin Breast Cancer; 2018 Oct; 18(5):e1149-e1163. PubMed ID: 29885789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
    Liu Y; Ide Y; Inuzuka M; Tazawa S; Kanada Y; Matsunaga Y; Kuwayama T; Sawada T; Akashi-Tanaka S; Nakamura S
    Mol Genet Genomic Med; 2019 Mar; 7(3):e493. PubMed ID: 30652428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor, progesterone receptor, and HER2-neu expression in first primary breast cancers and risk of second primary contralateral breast cancer.
    Saltzman BS; Malone KE; McDougall JA; Daling JR; Li CI
    Breast Cancer Res Treat; 2012 Oct; 135(3):849-55. PubMed ID: 22903686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abundant tumor infiltrating lymphocytes after primary systemic chemotherapy predicts poor prognosis in estrogen receptor-positive/HER2-negative breast cancers.
    Watanabe T; Hida AI; Inoue N; Imamura M; Fujimoto Y; Akazawa K; Hirota S; Miyoshi Y
    Breast Cancer Res Treat; 2018 Feb; 168(1):135-145. PubMed ID: 29168063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.
    Wong SM; King T; Boileau JF; Barry WT; Golshan M
    Ann Surg Oncol; 2017 Sep; 24(9):2509-2517. PubMed ID: 28455673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and biological characteristics of male breast cancer in Italy.
    Mangone L; Ferrari F; Mancuso P; Carrozzi G; Michiara M; Falcini F; Piffer S; Filiberti RA; Caldarella A; Vitale F; Tumino R; Brustolin A; Tagliabue G; Giorgi Rossi P; Ottini L
    Breast Cancer; 2020 Jul; 27(4):724-731. PubMed ID: 32114665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second Primary Malignancies in Patients with Colorectal Cancer: A Population-Based Analysis.
    Jia H; Li Q; Yuan J; Sun X; Wu Z
    Oncologist; 2020 Apr; 25(4):e644-e650. PubMed ID: 31943509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrepancies Between Pathological Tumor Responses and Estimations of Complete Response by Magnetic Resonance Imaging After Neoadjuvant Chemotherapy Differ by Breast Cancer Subtype.
    Namura M; Tsunoda H; Yagata H; Hayashi N; Yoshida A; Morishita E; Takei J; Suzuki K; Yamauchi H
    Clin Breast Cancer; 2018 Apr; 18(2):128-134. PubMed ID: 28843513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of second primary malignant neoplasm in Malwa region of central India.
    Naik A; Bhandari V; Saadvik RY; Gupta KL; Kausar M; Batra M
    J Cancer Res Ther; 2018; 14(5):999-1004. PubMed ID: 30197338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes in patients with early-stage breast cancer who underwent a 21-gene expression assay.
    Barcenas CH; Raghavendra A; Sinha AK; Syed MP; Hsu L; Patangan MG; Chavez-MacGregor M; Shen Y; Hortobagyi GH; Valero V; Giordano SH; Ueno NT; Tripathy D
    Cancer; 2017 Jul; 123(13):2422-2431. PubMed ID: 28199747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary gastric cancer malignancies following a breast cancer diagnosis: A population-based analysis.
    Mahar AL; Kagedan DJ; Hallet J; Coburn NG
    Breast; 2017 Jun; 33():34-37. PubMed ID: 28279886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Possible Association Between Thyroid Cancer and Breast Cancer.
    An JH; Hwangbo Y; Ahn HY; Keam B; Lee KE; Han W; Park DJ; Park IA; Noh DY; Youn YK; Cho BY; Im SA; Park YJ
    Thyroid; 2015 Dec; 25(12):1330-8. PubMed ID: 26442580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.